CVS Caremark

Pharma

CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now

The owner of the U.S.’ largest pharmacy benefit manager won't cover Gilead Sciences’ long-acting HIV prevention drug Yeztugo, at least for now.

Fraiser Kansteiner Aug 21, 2025 3:02pm

Wegovy

Novo's Wegovy secures preferred obesity spot on CVS formulary

May 1, 2025 2:39pm

CVS Health store front

CVS to replace branded Humira with biosims on some formularies

Jan 4, 2024 11:38am

CivicaPetersburg

Civica Rx draws $50M from California to produce low-cost insulin

Mar 20, 2023 11:45am

BMS flag

CVS Health returns BMS, Pfizer's Eliquis to formulary

Jun 24, 2022 8:29am

Gavel

Sanofi, Lilly and Novo must face RICO claims over insulin costs

Jul 13, 2021 12:23pm